Study reveals acupuncture and massage as effective pain management in advanced cancer

In a clinical trial, acupuncture and massage therapy significantly reduced pain, fatigue, and insomnia, enhancing quality of life in advanced cancer patients over 26 weeks.

I Never Expected to Run a Code While Running the NYC Marathon

I’d seen a 78-year-old in cardiac arrest before. In fact, I’ve resuscitated thousands, and run countless codes in 30-plus years as an emergency medicine nurse

February 14, 2024

WuXi fallout reverberates; Pharma’s top R&D spenders; Lilly teams up with Amazon; Historic NASH approval; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

March 17, 2024

Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder | Psychedelic Invest

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative

August 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.